Yann Fleureau
Advisor & Investor @ Various Companies & Startups
Paris, France
Yann Fleureau is a Series A investor at Various Companies & Startups in Paris focused on Health Care and Medical Device. Yann Fleureau is based ourt of France and is the Co-Founder of Project Numina. Yann previously worked at Cardiologs as a Co-founder and General Manager. Yann Fleureau attended Ecole Polytechnique.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Yann Fleureau invests in
Stages Yann Fleureau invests in
Countries Yann Fleureau invests in
Round sizes
Round size
- Series A
- $11M–$31M
Investment Focus
Industry
- Health Care 3 (43%)
- Medical Device 3 (43%)
- Gaming 1 (14%)
- Medical 1 (14%)
- Big Data 1 (14%)
Stage
- Series A 4 (57%)
- Seed 1 (14%)
- Pre-Seed 1 (14%)
- Series B 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Brink Therapeutics is a Biotechnology Research firm conducting cell therapy research using reprogrammed recombinases. | $4M / Seed / Apr 16, 2025 | |
|
|
InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters. | $16.7M / Series A / Sep 19, 2024 | |
|
|
Tilak is a unique videogame studio where like-minded & passionate people create fun mobile medical games to monitor patients with chronic diseases. | $10.5M / Series A / Oct 12, 2023 | |
|
|
Kestra is an infinitely scalable orchestration and scheduling platform, creating, running, scheduling, and monitoring millions of complex pipelines. | $3M / Pre-Seed / Oct 04, 2023 | |
|
|
Sonio is an artificial intelligence for fetal ultrasound, helping practitioners analyse and diagnose congenital malformations. | $14.3M / Series A / Jul 11, 2023 | |
|
|
MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room. | $55.4M / Series B / May 17, 2023 | |
|
|
MastOR is a medical device company developing a surgical robot for laparoscopy assistance. MastOR is an early-stage surgical robotics company whose laparoscopy assistance platform broadens access to minimally-invasive techniques for surgeons and optimizes resource utilization in the operating room. | $31.3M / Series A / Jun 07, 2022 |
Co-Investors
About Various Companies & Startups
Various Companies & Startups Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mike Wakerly
Investor and Advisor
|
|||
|
Yann Fleureau
Advisor & Investor
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Yann Fleureau invest in?
Yann Fleureau invests primarily in Health Care, Medical Device and Gaming startups, most often at Series A and Seed stage. Most of the 7 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Yann Fleureau's check size?
Yann Fleureau typically joins rounds of $11M–$31M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yann Fleureau participates in.
When did Yann Fleureau last invest?
The most recent investment recorded for Yann Fleureau closed in Apr 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!